Search Results 51-60 of 17768 for Alcoholics

  1. Excessive alcohol use can harm the body in many ways, including an increase in the risk of various cancers. It damages liver cel

    Andrew Keaveny, M.D.. Transplant Hepatology. Mayo Clinic. "There is a condiHon called acute alcoholic hepaHHs, where the alcohol triggers an acute inflammatory ...

  2. Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE) - Mayo Clinic

    Clinical Trials · Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE) · More about research at Mayo Clinic.

  3. Housecall: Alcohol - risks, benefits and why moderation is key - Mayo Clinic News Network

    Share this: Share to facebook · Share to twitter · Share to linkedin · Share to email Print. different kinds of alcoholic drinks in various glasses with a white ...

  4. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

    Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension · Overview · Participation ...

  5. Nonalcoholic Fatty Liver Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.

  6. Mayo Clinic Minute: Why alcohol and menopause can be a dangerous mix

    Hot flashes. Night sweats. Sleep problems. Weight gain. Menopause can seem like a rollercoaster with symptoms that can make life challenging.

  7. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Clinical Trials · Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis · More about research at Mayo ...

  8. Esophageal varices - Symptoms and causes - Mayo Clinic

    Several liver diseases — including hepatitis infection, alcoholic liver disease, fatty liver disease and a bile duct disorder called primary biliary cholangitis ...

  9. A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis · Overview · Participation ...

  10. Naltrexone (oral route) - Side effects & dosage - Mayo Clinic

    Naltrexone is used to help patient with opioid use disorder who have stopped taking opioids to stay drug-free and maintain their recovery. It is also used to ...